Thermo Fisher Scientific (TMO) Net Income towards Common Stockholders (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Net Income towards Common Stockholders for 18 consecutive years, with $1.7 billion the latest figure, recorded in Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at $1.7 billion, up 9.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 billion (up 6.12% YoY), and the FY2025 annual result was $6.8 billion, up 6.61% from the prior year.
• Net Income towards Common Stockholders was $1.7 billion for Q1 2026 at Thermo Fisher Scientific, down from $2.0 billion in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $2.2 billion in Q2 2022 and troughed at $1.3 billion in Q2 2023.
• Average Net Income towards Common Stockholders over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2023.
• The widest YoY moves for Net Income towards Common Stockholders: up 14.72% in 2023, down 41.81% in 2023.
• Over 5 years, Net Income towards Common Stockholders stood at $1.6 billion in 2022, then gained by 3.43% to $1.6 billion in 2023, then increased by 12.27% to $1.8 billion in 2024, then advanced by 8.91% to $2.0 billion in 2025, then decreased by 16.86% to $1.7 billion in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $1.7 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.6 billion in Q3 2025.